Delivery Order SPE2DB20D3103-SPE2DB25FP4B4
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,341.02, is for the supply of Mekinist 2 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with a period of performance through February 27, 2025. It was awarded on February 5, 2025 and does not have a set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $19,341.02 and a performance period through June 2, 2025. The contract is designated as a Firm Fixed Price Delivery Order, without any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This is a $8,878.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4563518616 Mekinist 2 mg tablets, with a completion date of February 23, 2024. This contract is a part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
- This is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $8,878.79, is for the Mekinist 2 mg tablet drug product. The...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,018.12, is for the delivery of MEKINIST 2 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of MEKINIST 2 MG TABLET pharmaceutical products, with a ceiling value of $17,018.12 and a period of performance through April 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,714.72 fixed-price delivery order is for the supply of MEKINIST 0.5 MG TABLET medical products, with a period of performance through July 31, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $4,460.92. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product MEKINIST 0.05 MG/ML SOLUTION 90ML. The contract has an Ultimate Completion Date of June 30, 2025 and was awarded on June 6, 2025. The contract is not designated as a Set-Aside. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of MEKINIST 2 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,878.79 firm fixed price delivery order was issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,341.02 firm fixed-price delivery order is for the supply of 4,568,131,488 units of the medication MEKINIST 2MG TAB 30S. The contract has an ultimate completion date of May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP4B4Delivery Order
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug Mekinist 2 mg Tablet, with a total ceiling value of $9,670.51 and a period of performance through July 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is issued under that larger IDC contract, allowing Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not designated as a set-aside, indicating open competition. As a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems, Amerisourcebergen Drug Corp leverages its extensive capabilities to fulfill diverse pharmaceutical and medical supply requirements for government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 7/7/25 |